245 results on '"Fragai M"'
Search Results
52. Catalytic domain of human Serine/Threonine Phosphatase 5 (PP5c)with two Zn2+ atoms complexed with cantharidic acid
- Author
-
Bertini, I., primary, Calderone, V., additional, Fragai, M., additional, Luchinat, C., additional, and Talluri, E., additional
- Published
- 2009
- Full Text
- View/download PDF
53. Catalytic domain of human Serine/Threonine Phosphatase 5 (PP5c)with two Mn2+ atoms
- Author
-
Bertini, I., primary, Calderone, V., additional, Fragai, M., additional, Luchinat, C., additional, and Talluri, E., additional
- Published
- 2009
- Full Text
- View/download PDF
54. Catalytic domain of human Serine/Threonine Phosphatase 5 (PP5c) with two Mn2+ atoms originally soaked with cantharidin (which is present in the structure in the hydrolyzed form)
- Author
-
Bertini, I., primary, Calderone, V., additional, Fragai, M., additional, Luchinat, C., additional, and Talluri, E., additional
- Published
- 2009
- Full Text
- View/download PDF
55. Structural Basis of Serine/Threonine Phosphatase Inhibition by the Archetypal Small Molecules Cantharidin and Norcantharidin
- Author
-
Bertini, I., primary, Calderone, V., additional, Fragai, M., additional, Luchinat, C., additional, and Talluri, E., additional
- Published
- 2009
- Full Text
- View/download PDF
56. Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2-nitroso-2-oxoethyl)benzenesulfonamide
- Author
-
Bertini, I., primary, Calderone, V., additional, Fragai, M., additional, Giachetti, A., additional, Loconte, M., additional, Luchinat, C., additional, Maletta, M., additional, Nativi, C., additional, and Yeo, K.J., additional
- Published
- 2008
- Full Text
- View/download PDF
57. Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2-hydroxyethyl)-N-(2-nitroso-2-oxoethyl)benzenesulfonamide
- Author
-
Bertini, I., primary, Calderone, V., additional, Fragai, M., additional, Giachetti, A., additional, Loconte, M., additional, Luchinat, C., additional, Maletta, M., additional, Nativi, C., additional, and Yeo, K.J., additional
- Published
- 2008
- Full Text
- View/download PDF
58. Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-(2-nitroso-2-oxoethyl)benzenesulfonamide
- Author
-
Bertini, I., primary, Calderone, V., additional, Fragai, M., additional, Giachetti, A., additional, Loconte, M., additional, Luchinat, C., additional, Maletta, M., additional, Nativi, C., additional, and Yeo, K.J., additional
- Published
- 2008
- Full Text
- View/download PDF
59. Crystal structure of full-length human MMP-12
- Author
-
Bertini, I., primary, Calderone, V., additional, Fragai, M., additional, Jaiswal, R., additional, Luchinat, C., additional, Melikian, M., additional, Myonas, E., additional, and Svergun, D.I., additional
- Published
- 2008
- Full Text
- View/download PDF
60. Solution structure of the hemopexin-like domain of MMP12
- Author
-
Bertini, I., primary, Calderone, V., additional, Fragai, M., additional, Jaiswal, R., additional, Luchinat, C., additional, and Melikian, M., additional
- Published
- 2008
- Full Text
- View/download PDF
61. Human MMP-8 in complex with peptide IAG
- Author
-
Calderone, V., primary, Bertini, I., additional, Fragai, M., additional, Luchinat, C., additional, Maletta, M., additional, and Yeo, K.J., additional
- Published
- 2007
- Full Text
- View/download PDF
62. Human MMP-12 complexed with the peptide IAG
- Author
-
Calderone, V., primary, Bertini, I., additional, Fragai, M., additional, Luchinat, C., additional, Maletta, M., additional, and Yeo, K.J., additional
- Published
- 2007
- Full Text
- View/download PDF
63. Human MMP-12 in complex with two peptides PQG and IAG
- Author
-
Calderone, V., primary, Bertini, I., additional, Fragai, M., additional, Luchinat, C., additional, Maletta, M., additional, and Yeo, K.J., additional
- Published
- 2007
- Full Text
- View/download PDF
64. Uninhibited form of human MMP-12
- Author
-
Calderone, V., primary, Bertini, I., additional, Fragai, M., additional, Luchinat, C., additional, Maletta, M., additional, and Yeo, K.J., additional
- Published
- 2007
- Full Text
- View/download PDF
65. Uninhibited human MMP-8
- Author
-
Calderone, V., primary, Bertini, I., additional, Fragai, M., additional, Luchinat, C., additional, Maletta, M., additional, and Yeo, K.J., additional
- Published
- 2007
- Full Text
- View/download PDF
66. Crystal structure of human MMP-12 in complex with acetohydroxamic acid and a bicyclic inhibitor
- Author
-
Mannino, C., primary, Nievo, M., additional, Machetti, F., additional, Papakyriakou, A., additional, Calderone, V., additional, Fragai, M., additional, and Guarna, A., additional
- Published
- 2006
- Full Text
- View/download PDF
67. Crystal structure of the catalytic domain of human MMP12 complexed with acetohydroxamic acid at atomic resolution
- Author
-
Bertini, I., primary, Calderone, V., additional, Cosenza, M., additional, Fragai, M., additional, Lee, Y.-M., additional, Luchinat, C., additional, Mangani, S., additional, Terni, B., additional, and Turano, P., additional
- Published
- 2005
- Full Text
- View/download PDF
68. Crystal structure of the catalytic domain of human matrix metalloproteinase 10
- Author
-
Calderone, V., primary, Bertini, I., additional, Fragai, M., additional, Luchinat, C., additional, Mangani, S., additional, and Terni, B., additional
- Published
- 2004
- Full Text
- View/download PDF
69. Crystal Structure of the Catalytic Domain of Human Matrix Metalloproteinase 10
- Author
-
Bertini, I., primary, Calderone, V., additional, Fragai, M., additional, Luchinat, C., additional, Mangani, S., additional, and Terni, B., additional
- Published
- 2004
- Full Text
- View/download PDF
70. 1H NMRD dispersions of porous media: a model-free analysis
- Author
-
Fragai, M., primary, Luchinat, C., additional, Nerinovski, K., additional, and Parigi, G., additional
- Published
- 2001
- Full Text
- View/download PDF
71. Combining in Silico Tools and NMR Data To Validate Protein−Ligand Structural Models: Application to Matrix Metalloproteinases
- Author
-
Bertini, I., Fragai, M., Giachetti, A., Luchinat, C., Maletta, M., Parigi, G., and Yeo, K. J.
- Abstract
A combination of in silico tools and experimental NMR data is proposed for relatively fast determination of protein−ligand structural models and demonstrated from known inhibitors of matrix metalloproteinases (MMP). The 15N 1H heteronuclear single quantum coherence (HSQC) spectral assignment and the 3D structure, either X-ray or NMR, are needed. In this method, the HSQC spectrum with or without the ligand is used to determine the interaction region of the ligand. Docking calculations are then performed to obtain a set of structural models. From the latter, the nuclear Overhauser effects (NOEs) between the ligand and the protein can be predicted. Guided by these predictions, a number of NOEs can be detected and assigned through a HSQC NOESY experiment. These data are used as structural restraints to reject/refine the initial structural models through further in silico work. For a test protein (MMP-12, human macrophage metalloelastase), a final structure of a protein−ligand adduct was obtained that matches well with the full structural determination. A number of structural predictions were then made for adducts of a similar protein (MMP-1, human fibroblast collagenase) with the same and different ligands. The quality of the final results depended on the type and number of experimental NOEs, but in all cases, a well-defined ligand conformation in the protein binding site was obtained. This protocol is proposed as a viable alternative to the many approaches described in the literature.
- Published
- 2005
72. α,α'-Dioxothiones, III. - Regio- and stereoselective ene and tandem 'ene-cycloaddition' reactions of 2,4-dioxopentane-3-thione
- Author
-
Capozzi, G., Fragai, M., STEFANO MENICHETTI, and Nativi, C.
73. NMRD measurements
- Author
-
Fragai, M., Ferrante, G., Luchinat, C., and Kirill Nerinovski
74. The G-triplex DNA
- Author
-
Sandro Cosconati, Linda Cerofolini, Marco Fragai, Stefano De Tito, Claudio Luchinat, Antonio Randazzo, Roberta Trotta, Luciana Marinelli, Bruno Pagano, Michele Parrinello, Ivano Bertini, Vittorio Limongelli, Ettore Novellino, Limongelli, V, De Tito, S, Cerofolini, L, Fragai, M, Pagano, B, Trotta, R, Cosconati, Sandro, Marinelli, L, Novellino, E, Bertini, I, Randazzo, A, Luchinat, C, Parrinello, M., Limongelli, Vittorio, De Tito, S., Cerofolini, L., Fragai, M., Pagano, Bruno, Trotta, R., Cosconati, S., Marinelli, Luciana, Novellino, Ettore, Bertini, I., Randazzo, Antonio, and Luchinat, C.
- Subjects
Magnetic Resonance Spectroscopy ,DNA Folding ,Stacking ,010402 general chemistry ,01 natural sciences ,triplex DNA ,Catalysis ,DSC ,03 medical and health sciences ,chemistry.chemical_compound ,thermodynamic ,NMR spectroscopy ,Macromolecular docking ,Structural motif ,030304 developmental biology ,0303 health sciences ,Oligonucleotide ,Metadynamics ,General Chemistry ,DNA ,NMR ,0104 chemical sciences ,Crystallography ,G-triplex ,chemistry ,Duplex (building) ,Physical chemistry ,metadynamic ,Nucleic Acid Conformation ,quadruplex DNA - Abstract
Nucleic acids represent the alphabet of the cellular language and through their sequence and topology regulate vital cellular functions. In recent years, it has been found that many variations from the Watson–Crick duplex structure play key roles in many cellular processes. Examples are hairpins, cruciforms, parallel-stranded duplexes, triplexes, G-quadruplexes, and the i-motif. These structures can be formed by nucleotide sequences distributed throughout the whole human genome, their location is not random and often associated with human diseases. These complexes are formed from one to four strands, stabilized by base stacking and hydrogen bond interactions, with a variety of non-standard pairings. For instance, DNA triplexes can present G:G-C, A:A-T, C:G-C, and T:A-T pairings, with two strands in the standard Watson–Crick duplex structure (i.e. G-C and A-T) and the third one lying in the major groove of the duplex. In contrast, G-quadruplexes are four-stranded structures stabilized by stacking of two or more guanine tetrads (Figure 1). These examples highlight the structural polymorphism of DNA and suggest that other structures might exist, perhaps with specific cellular functions that are, to date, unknown. Herein, using metadynamics simulations, we have identified a stable folding intermediate of the thrombin binding aptamer (TBA) quadruplex. This intermediate is characterized by a “G-triplex” structure, having G:G:G triad planes stabilized by an array of Hoogsteen-like hydrogen-bonds (Figure 1). This kind of structure has been already hypothesized in other investigations on different DNA sequences, but never experimentally proven. Herein, for the first time, we have structurally and thermodynamically characterized this DNA structural motif, through a combination of biophysical experiments. Well-tempered metadynamics simulations have been used to study the folding of TBA, which is a 15-mer oligonucleotide (5’-dGGTTGGTGTGGTTGG-3’) organized in an anti-parallel monomolecular G-quadruplex with a chairlike structure (Figure 2a). This structure consists of two Gtetrads, able to coordinate a metal ion at the center, connected by two TT loops and a single TGT loop. Metadynamics accelerates the sampling, adding a bias on a few degrees of freedom of the system, called collective variables (CVs). In such a way, long time scale events, such as ligand/protein docking or protein/DNA folding, can be sampled in an affordable computational time and the free energy surface (FES) of the process can be computed. In the present case, the FES was calculated as a function of two CVs, the radius of gyration CV defined by the oxygen atoms of the guanines forming the G-tetrads and a second CV that counts the number of hydrogen bonds between these guanines (see Supporting Information). Looking at the FES obtained after approximately 80 ns of metadynamics simulation, three main energy minima can be identified (Figure 2b). The deepest one, basin A, corresponds to the experimental G-quadruplex structure of TBA. In the second minimum, basin B, TBA shows a partial opening of the 3’ end with residue G15
- Published
- 2012
75. Molecular recognition of sialoglycans by streptococcal Siglec-like adhesins: toward the shape of specific inhibitors
- Author
-
Cristina Di Carluccio, Alba Silipo, Yoshiyuki Manabe, Roberta Marchetti, Marco Fragai, Elio Pizzo, Rosa Ester Forgione, Barbara A. Bensing, Koichi Fukase, Antonio Molinaro, Andrea Bosso, Shinji Yokoyama, Di Carluccio, C., Forgione, R. E., Bosso, A., Yokoyama, S., Manabe, Y., Pizzo, E., Molinaro, A., Fukase, K., Fragai, M., Bensing, B. A., Marchetti, R., and Silipo, A.
- Subjects
0303 health sciences ,Glycan ,biology ,Streptococcus gordonii ,SIGLEC ,010402 general chemistry ,biology.organism_classification ,Oral cavity ,01 natural sciences ,Biochemistry, Genetics and Molecular Biology (miscellaneous) ,Biochemistry ,0104 chemical sciences ,3. Good health ,Microbiology ,Bacterial adhesin ,Chemistry ,03 medical and health sciences ,Strain specificity ,Streptococcus sanguinis ,Molecular recognition ,Chemistry (miscellaneous) ,biology.protein ,Molecular Biology ,030304 developmental biology - Abstract
Streptococcus gordonii and Streptococcus sanguinis, commensal bacteria present in the oral cavity of healthy individuals, upon entry into the bloodstream can become pathogenic, causing infective endocarditis (IE). Sialic acid-binding serine-rich repeat adhesins on the microbial surface represent an important factor of successful infection to cause IE. They contain Siglec-like binding regions (SLBRs) that variously recognize different repertoires of O-glycans, with some strains displaying high selectivity and others broader specificity. We here dissect at an atomic level the mechanism of interaction of SLBR-B and SLBR-H from S. gordonii with a multivarious approach that combines NMR spectroscopy and computational and biophysical studies. The binding pockets of both SLBRs are broad enough to accommodate extensive interactions with sialoglycans although with key differences related to strain specificity. Furthermore, and significantly, the pattern of interactions established by the SLBRs are mechanistically very different from those reported for mammalian Siglecs despite them having a similar fold. Thus, our detailed description of the binding modes of streptococcal Siglec-like adhesins sparks the development of tailored synthetic inhibitors and therapeutics specific for Streptococcal adhesins to counteract IE, without impairing the interplay between Siglecs and glycans., We here present a detailed molecular description of sialoglycans recognition by Siglec-like adhesins from S. gordonii opening the venue for the design of specific inhibitors to influence the propensity of streptococci to cause infective endocarditis.
- Published
- 2021
76. Insights into telomeric G-quadruplex DNA recognition by HMGB1 protein
- Author
-
Claudio Luchinat, Antonio Rosato, Jussara Amato, Ettore Novellino, Annamaria Biroccio, Linda Cerofolini, Stefano Giuntini, Bruno Pagano, Antonio Randazzo, Diego Brancaccio, Marco Fragai, Sara Iachettini, Pasquale Zizza, Nunzia Iaccarino, Amato, J., Cerofolini, L., Brancaccio, D., Giuntini, S., Iaccarino, N., Zizza, P., Iachettini, S., Biroccio, A., Novellino, E., Rosato, A., Fragai, M., Luchinat, C., Randazzo, A., and Pagano, B.
- Subjects
Cell biology ,DNA repair ,DNA damage ,chemical and pharmacologic phenomena ,Biology ,G-quadruplex ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Structural Biology ,Transcription (biology) ,Escherichia coli ,Genetics ,Humans ,Gene silencing ,HMGB1 Protein ,Telomerase ,030304 developmental biology ,0303 health sciences ,DNA ,Telomere ,G-Quadruplexes ,chemistry ,Nucleic acid ,030220 oncology & carcinogenesis ,Magnetic Resonance Spectroscopy, Protein, K+ SOLUTION, BINDING, DOMAIN, CELLS, BOXES, D(TTAGGGT)(4), POLYMORPHISM, EXTENSION, COMPLEX ,Nucleic Acid Conformation - Abstract
HMGB1 is a ubiquitous non-histone protein, which biological effects depend on its expression and subcellular location. Inside the nucleus, HMGB1 is engaged in many DNA events such as DNA repair, transcription and telomere maintenance. HMGB1 has been reported to bind preferentially to bent DNA as well as to noncanonical DNA structures like 4-way junctions and, more recently, to G-quadruplexes. These are four-stranded conformations of nucleic acids involved in important cellular processes, including telomere maintenance. In this frame, G-quadruplex recognition by specific proteins represents a key event to modulate physiological or pathological pathways. Herein, to get insights into the telomeric G-quadruplex DNA recognition by HMGB1, we performed detailed biophysical studies complemented with biological analyses. The obtained results provided information about the molecular determinants for the interaction and showed that the structural variability of human telomeric G-quadruplex DNA may have significant implications in HMGB1 recognition. The biological data identified HMGB1 as a telomere-associated protein in both telomerase-positive and -negative tumor cells and showed that HMGB1 gene silencing in such cells induces telomere DNA damage foci. Altogether, these findings provide a deeper understanding of telomeric G-quadruplex recognition by HMGB1 and suggest that this protein could actually represent a new target for cancer therapy.
- Published
- 2019
77. Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors
- Author
-
Linda Cerofolini, Gerolama Condorelli, Giovanna Polcaro, Daniela Arosio, Vincenzo Maria D'Amore, Stefano Pepe, Riccardo Scaglia, Marco Fragai, E. Novellino, Giulia Assoni, Luciana Marinelli, Pasquale Russomanno, Stefano Giuntini, Jussara Amato, Diego Brancaccio, Francesco Sabbatino, Marianna Falzoni, Valeria La Pietra, Greta Donati, Paolo Orlando, Pierfausto Seneci, Cristina Quintavalle, Martina Pedrini, Bruno Pagano, Russomanno, P., Assoni, G., Amato, J., D'Amore, V. M., Scaglia, R., Brancaccio, D., Pedrini, M., Polcaro, G., La Pietra, V., Orlando, P., Falzoni, M., Cerofolini, L., Giuntini, S., Fragai, M., Pagano, B., Donati, G., Novellino, E., Quintavalle, C., Condorelli, G., Sabbatino, F., Seneci, P., Arosio, D., Pepe, S., and Marinelli, L.
- Subjects
Models, Molecular ,medicine.drug_class ,Immune Checkpoint Inhibitor ,B7-H1 Antigen ,Calorimetry, Differential Scanning ,Cell Line, Tumor ,Coculture Techniques ,Humans ,Immune Checkpoint Inhibitors ,Neoplasms ,Small Molecule Libraries ,Structure-Activity Relationship ,Triazines ,Calorimetry ,Monoclonal antibody ,Differential Scanning ,Peripheral blood mononuclear cell ,PD-1/PD-L1 ,Cell Line ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Small Molecule Librarie ,Models ,PD-L1 ,Drug Discovery ,medicine ,Cytotoxicity ,Coculture Technique ,immune checkpoint ,030304 developmental biology ,0303 health sciences ,Tumor ,biology ,Chemistry ,Molecular ,Small molecule ,3. Good health ,Triazine ,Apoptosis ,030220 oncology & carcinogenesis ,Cancer cell ,Cancer research ,biology.protein ,Molecular Medicine ,Neoplasm ,Human - Abstract
The inhibition of the PD-1/PD-L1 axis by monoclonal antibodies has achieved remarkable success in treating a growing number of cancers. However, a novel class of small organic molecules, with BMS-202 (1) as the lead, is emerging as direct PD-L1 inhibitors. Herein, we report a series of 2,4,6-tri- and 2,4-disubstituted 1,3,5-triazines, which were synthesized and assayed for their PD-L1 binding by NMR and homogeneous time-resolved fluorescence. Among them, compound 10 demonstrated to strongly bind with the PD-L1 protein and challenged it in a co-culture of PD-L1 expressing cancer cells (PC9 and HCC827 cells) and peripheral blood mononuclear cells enhanced antitumor immune activity of the latter. Compound 10 significantly increased interferon γ release and apoptotic induction of cancer cells, with low cytotoxicity in healthy cells when compared to 1, thus paving the way for subsequent preclinical optimization and medical applications.
- Published
- 2021
78. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme
- Author
-
Claudia Martini, Valeria La Pietra, Romano Silvestri, Linda Cerofolini, Simona Daniele, Michela Puxeddu, Sabrina Taliani, Chiara Cavallini, Martina Pedrini, Stefano Giuntini, Marianna Nalli, Vincenzo Maria D'Amore, Luciana Marinelli, Marco Fragai, Claudio Luchinat, Ettore Novellino, Deborah Pietrobono, Rebecca Piccarducci, Giuseppe La Regina, Pasquale Russomanno, Daniele, S., La Pietra, V., Piccarducci, R., Pietrobono, D., Cavallini, C., D'Amore, V. M., Cerofolini, L., Giuntini, S., Russomanno, P., Puxeddu, M., Nalli, M., Pedrini, M., Fragai, M., Luchinat, C., Novellino, E., Taliani, S., La Regina, G., Silvestri, R., Martini, C., and Marinelli, L.
- Subjects
0301 basic medicine ,p53 ,Benzylamines ,Indoles ,Cell Cycle Proteins ,Cyclams ,CXCR4 ,Benzylamine ,0302 clinical medicine ,Cell Movement ,Cell Cycle Protein ,Antineoplastic Combined Chemotherapy Protocols ,Proto-Oncogene Protein ,CXCR4 antagonist ,biology ,Chemistry ,GBM stem-Like cells (GSCs) ,Brain Neoplasms ,Drug Synergism ,Proto-Oncogene Proteins c-mdm2 ,Cyclam ,Neoplastic Stem Cells ,Mdm2 ,Stem cell ,Human ,Signal Transduction ,Receptors, CXCR4 ,Neurogenesis ,Brain Neoplasm ,03 medical and health sciences ,MDM4 ,Downregulation and upregulation ,MDM2 ,Glioma ,Neurosphere ,Cell Line, Tumor ,Proto-Oncogene Proteins ,Spheroids, Cellular ,medicine ,Humans ,Neoplasm Invasiveness ,Cell Proliferation ,Pharmacology ,Neoplasm Invasivene ,Glioblastoma multiforme (GBM) ,Antineoplastic Combined Chemotherapy Protocol ,medicine.disease ,030104 developmental biology ,Indole ,Cancer cell ,biology.protein ,Cancer research ,Neurogenesi ,Neoplastic Stem Cell ,Tumor Suppressor Protein p53 ,Glioblastoma ,030217 neurology & neurosurgery - Abstract
Glioblastoma Multiforme (GBM) is a highly invasive primary brain tumour characterized by chemo- and radio-resistance and poor overall survival. GBM can present an aberrant functionality of p53, caused by the overexpression of the murine double minute 2 protein (MDM2) and its analogue MDM4, which may influence the response to conventional therapies. Moreover, tumour resistance/invasiveness has been recently attributed to an overexpression of the chemokine receptor CXCR4, identified as a pivotal mediator of glioma neovascularization. Notably, CXCR4 and MDM2-4 cooperate in promoting tumour invasion and progression. Although CXCR4 actively promotes MDM2 activation leading to p53 inactivation, MDM2-4 knockdown induces the downregulation of CXCR4 gene transcription. Our study aimed to assess if the CXCR4 signal blockade could enhance glioma cells' sensitivity to the inhibition of the p53-MDMs axis. Rationally designed inhibitors of MDM2/4 were combined with the CXCR4 antagonist, AMD3100, in human GBM cells and GBM stem-like cells (neurospheres), which are crucial for tumour recurrence and chemotherapy resistance. The dual MDM2/4 inhibitor RS3594 and the CXCR4 antagonist AMD3100 reduced GBM cell invasiveness and migration in single-agent treatment and mainly in combination. AMD3100 sensitized GBM cells to the antiproliferative activity of RS3594. It is noteworthy that these two compounds present synergic effects on cancer stem components: RS3594 inhibited the growth and formation of neurospheres, AMD3100 induced differentiation of neurospheres while enhancing RS3594 effectiveness preventing their proliferation/clonogenicity. These results confirm that blocking CXCR4/MDM2/4 represents a valuable strategy to reduce GBM proliferation and invasiveness, acting on the stem cell component too.
- Published
- 2020
79. HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein–Protein Interactions by NMR
- Author
-
Stefano Tomassi, Salvatore Di Maro, Claudio Luchinat, Stefano Giuntini, Ettore Novellino, Alfonso Carotenuto, Pasquale Russomanno, Marco Fragai, Linda Cerofolini, Antonio Limatola, Diego Brancaccio, Francesco Merlino, Brancaccio, Diego, Di Maro, Salvatore, Cerofolini, Linda, Giuntini, Stefano, Fragai, Marco, Luchinat, Claudio, Tomassi, Stefano, Limatola, Antonio, Russomanno, Pasquale, Merlino, Francesco, Novellino, Ettore, Carotenuto, Alfonso, Brancaccio, D, Di Maro, S, Cerofolini, L, Giuntini, S, Fragai, M, Luchinat, C, Tomassi, S, Limatola, A, Russomanno, P, Merlino, F, Novellino, E, and Carotenuto, A.
- Subjects
chemistry.chemical_classification ,010405 organic chemistry ,Chemistry ,Organic Chemistry ,Cancer ,Screening assay ,Peptide ,macromolecular substances ,Computational biology ,medicine.disease ,01 natural sciences ,Biochemistry ,NMR ,0104 chemical sciences ,Protein–protein interaction ,010404 medicinal & biomolecular chemistry ,Drug Discovery ,medicine - Abstract
[Image: see text] Protein–protein interactions (PPIs) contribute to the onset and/or progression of several diseases, especially cancer, and this discovery has paved the way for considering disruption of the PPIs as an attractive anti-tumor strategy. In this regard, simple and efficient biophysical methods for detecting the interaction of the inhibitors with the protein counterpart are still in high demand. Herein, we describe a convenient NMR method for the screening of putative PPI inhibitors based on the use of “hot peptides” (HOPPI-NMR). As a case study, HOPPI-NMR was successful applied to the well-known p53/MDM2 system. Our outcomes highlight the main advantages of the method, including the use of a small amount of unlabeled proteins, the minimization of the risk of protein aggregation, and the ability to identify weak binders. The last leaves open the possibility for application of HOPPI-NMR in tandem with fragment-based drug discovery as a valid strategy for the identification of novel chemotypes acting as PPI inhibitors.
- Published
- 2020
80. A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer
- Author
-
Amedei, Amedeo, Asadzadeh, Fatemeh, Papi, Francesco, Vannucchi, Maria Giuliana, Ferrucci, Veronica, Bermejo, Iris A., Fragai, Marco, De Almeida, Carolina Vieira, Cerofolini, Linda, Giuntini, Stefano, Bombaci, Mauro, Pesce, Elisa, Niccolai, Elena, Natali, Francesca, Guarini, Eleonora, Gabel, Frank, Traini, Chiara, Catarinicchia, Stefano, Ricci, Federica, Orzalesi, Lorenzo, Berti, Francesco, Corzana, Francisco, Zollo, Massimo, Grifantini, Renata, Nativi, Cristina, 0000-0002-2143-046X, 0000-0001-8864-4852, 0000-0002-0795-9594, 0000-0002-1631-4624, 0000-0001-5597-8127, 0000-0002-6312-3230, Amedei, A., Asadzadeh, F., Papi, F., Vannucchi, M. G., Ferrucci, V., Bermejo, I. A., Fragai, M., De Almeida, C. V., Cerofolini, L., Giuntini, S., Bombaci, M., Pesce, E., Niccolai, E., Natali, F., Guarini, E., Gabel, F., Traini, C., Catarinicchia, S., Ricci, F., Orzalesi, L., Berti, F., Corzana, F., Zollo, M., Grifantini, R., and Nativi, C.
- Subjects
0301 basic medicine ,Immunology ,02 engineering and technology ,Medical Biochemistry ,Article ,03 medical and health sciences ,Breast cancer ,Immune system ,Antigen ,Tn antigen ,medicine ,lcsh:Science ,Triple-negative breast cancer ,Cancer ,Multidisciplinary ,biology ,business.industry ,021001 nanoscience & nanotechnology ,medicine.disease ,030104 developmental biology ,Tumor progression ,Cancer cell ,biology.protein ,Cancer research ,lcsh:Q ,Antibody ,0210 nano-technology ,business ,Vaccine - Abstract
Summary The Tn antigen is a well-known tumor-associated carbohydrate determinant, often incorporated in glycopeptides to develop cancer vaccines. Herein, four copies of a conformationally constrained mimetic of the antigen TnThr (GalNAc-Thr) were conjugated to the adjuvant CRM197, a protein licensed for human use. The resulting vaccine candidate, mime[4]CRM elicited a robust immune response in a triple-negative breast cancer mouse model, correlated with high frequency of CD4+ T cells and low frequency of M2-type macrophages, which reduces tumor progression and lung metastasis growth. Mime[4]CRM-mediated activation of human dendritic cells is reported, and the proliferation of mime[4]CRM-specific T cells, in cancer tissue and peripheral blood of patients with breast cancer, is demonstrated. The locked conformation of the TnThr mimetic and a proper presentation on the surface of CRM197 may explain the binding of the conjugate to the anti-Tn antibody Tn218 and its efficacy to fight cancer cells in mice., Graphical Abstract, Highlights • Structurally simple vaccine candidate reduces BC tumor size and delays lung metastasis • TnThr mimetic, fused to CRM197 adjuvant, is able to elicit T and B immune responses • TnThr mimetic-based vaccine candidate able to activate human DCs • The vaccine candidate recruits T helper CD4+ in the tumor microenvironment, Medical Biochemistry; Immunology; Cancer
- Published
- 2020
- Full Text
- View/download PDF
81. A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome
- Author
-
Marianna Mamusa, Alexandra Louka, Ettore Novellino, Claudiu T. Supuran, Elisa Dragoni, Barbara Richichi, Veronica Baldoneschi, G. De Rosa, Marco Fragai, S. Burgalassi, Cristina Nativi, Debora Berti, D. Monti, Daniela Vullo, Atilla Akdemir, AKDEMİR, ATİLLA, Richichi, B, Baldoneschi, V, Burgalassi, S, Fragai, M, Vullo, D, Akdemir, A, Dragoni, E, Louka, A, Mamusa, M, Monti, D, Berti, D, Novellino, Ettore, De Rosa, G, Supuran, C. T, and Nativi, C.
- Subjects
0301 basic medicine ,Carbonic Anhydrase Inhibitor ,medicine.drug_class ,Matrix metalloproteinase inhibitor ,metalloproteins ,Matrix metalloproteinase ,Matrix Metalloproteinase Inhibitors ,dendrimer ,dendrimers ,drug delivery ,drug discovery ,inhibitors ,Catalysis ,Divalent ,03 medical and health sciences ,Drug Delivery Systems ,medicine ,Animals ,Humans ,Carbonic anhydrase inhibitor ,Carbonic Anhydrase Inhibitors ,chemistry.chemical_classification ,Chemistry ,Animal ,Organic Chemistry ,Sulfonamide (medicine) ,metalloprotein ,General Chemistry ,Transmembrane protein ,Matrix Metalloproteinases ,inhibitor ,030104 developmental biology ,Enzyme ,Biochemistry ,Matrix Metalloproteinase Inhibitor ,Drug delivery ,Dry Eye Syndromes ,Drug Delivery System ,Dry Eye Syndrome ,RICHICHI B., BALDONESCHI V., BURGALASSI S., FRAGAI M., VULLO D., Akdemir A., DRAGONI E., LOUKA A., MAMUSA M., MONTI D., et al., -A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome.-, Chemistry (Weinheim an der Bergstrasse, Germany), cilt.22, ss.1714-21, 2016 ,medicine.drug ,Human - Abstract
Synthetic sulfonamide derivatives are a class of potent matrix metalloproteinase inhibitors (MMPI) that have potential for the treatment of diseases related to uncontrolled expression of these enzymes. The lack of selectivity of the large majority of such inhibitors, leading to the inhibition of MMPs in tissues other than the targeted one, has dramatically reduced the therapeutic interest in MMPIs. The recent development of efficient drug delivery systems that allow the transportation of a selected drug to its site of action has opened the way to new perspectives in the use of MMPIs. Here, a PAMAM-based divalent dendron with two sulfonamidic residues was synthesized. This nanomolar inhibitor binds to the catalytic domain of two MMPs as well as to the transmembrane human carbonic anhydrases (hCAs) XII, which is present in the eye and considered an antiglaucoma target. In the animal model of an experimental dry eye, no occurrence of dotted staining in eyes treated with our inhibitor was observed, indicating no symptoms of corneal desiccation.
- Published
- 2015
82. Activity of Anchored Human Matrix Metalloproteinase-1 Catalytic Domain on Au (111) Surfaces Monitored by ESI-MS
- Author
-
Andrea Picardi, Luca Domenico D'Andrea, Roberta D'Agata, Carlo Pedone, Alessandra Romanelli, Giuseppe Spoto, Giuseppe Grasso, Marco Fragai, Enrico Rizzarelli, Kwon Joo Yeo, Grasso, G., D'Agata, R., Rizzarelli, E., Spoto, G., D'Andrea, L., Pedone, Carlo, Picardi, A., Romanelli, Alessandra, Fragai, M., and Yeo, K. J.
- Subjects
Spectrometry, Mass, Electrospray Ionization ,matrix metalloproteinase ,Immobilized enzyme ,SPR ,Matrix Metalloproteinase Inhibitors ,Matrix metalloproteinase ,Hydroxamic Acids ,metalloproteinase-1 ,Extracellular matrix ,Surface immobilized proteins ,Catalytic Domain ,Cleave ,human fibroblast collagenase ,Humans ,Surface plasmon resonance ,Spectroscopy ,FT-SPR ,Sulfonamides ,Fourier Analysis ,biology ,Chemistry ,ESI-MS ,Surface Plasmon Resonance ,Enzymes, Immobilized ,In vitro ,activity assay ,Kinetics ,Biochemistry ,Enzyme inhibitor ,Biophysics ,biology.protein ,Gold ,Matrix Metalloproteinase 1 ,Oligopeptides ,Biosensor - Abstract
Matrix metalloproteinases (MMPs) are a family of Zn-dependent endo-peptidases known for their ability to cleave several components of the extracellular matrix, but which can also cleave many non-matrix proteins. There are many evidences that MMPs are involved in physiological and pathological processes, and a huge effort has been put in the development of possible inhibitors that could reduce the activity of MMPs, as it is clear that the ability to monitor and control such activity plays a pivotal role in the search for potential drugs aimed at finding a cure for several diseases such as pulmonary emphysema, rheumatoid arthritis, fibrotic disorders and cancer. A powerful method currently available to study enzyme–inhibitor interactions is based on the use of the surface plasmon resonance (SPR) technique. When MMP interactions are studied, a procedure by which inhibitors are normally anchored on sensor chips and SPR technique is used in order to study their interaction with MMPs molecules is usually followed. This is because it is currently believed that MMPs cannot be anchored on the sensor-chip surface without losing their activity. However, this approach gives rise to problems, as the anchoring of low-molecular-weight inhibitors on gold surfaces easily affects their ability to interact with MMPs. For this reason, the anchoring of MMPs is highly desirable. A new experimental protocol that couples the Fourier transform-SPR (FT-SPR) technique with electrospray ionization-mass spectroscopy (ESI-MS) is described here for the evaluation of the activity of MMP-1 catalytic domain (cdMMP-1) anchored on gold surfaces. The cdMMP-1 surface coverage is calculated by using FT-SPR and the enzyme activity is estimated by ESI-MS. The proposed method is label-free.
- Published
- 2005
83. The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity.
- Author
-
Garcia-Vello P, Tytgat HLP, Elzinga J, Van Hul M, Plovier H, Tiemblo-Martin M, Cani PD, Nicolardi S, Fragai M, De Castro C, Di Lorenzo F, Silipo A, Molinaro A, and de Vos WM
- Subjects
- Animals, Humans, Mice, Symbiosis, Mice, Inbred C57BL, Lipid A metabolism, Lipid A chemistry, Interleukin-10 metabolism, Gastrointestinal Microbiome, Liver metabolism, Liver microbiology, Female, Lipopolysaccharides, Akkermansia, Signal Transduction, Toll-Like Receptor 4 metabolism, Toll-Like Receptor 2 metabolism
- Abstract
The cell-envelope of Gram-negative bacteria contains endotoxic lipopolysaccharides (LPS) that are recognized by the innate immune system via Toll-Like Receptors (TLRs). The intestinal mucosal symbiont Akkermansia muciniphila is known to confer beneficial effects on the host and has a Gram-negative architecture. Here we show that A. muciniphila LPS lacks the O-polysaccharide repeating unit, with the resulting lipooligosaccharide (LOS) having unprecedented structural and signaling properties. The LOS consists of a complex glycan chain bearing two distinct undeca- and hexadecasaccharide units each containing three 2-keto-3-deoxy-D-manno-octulosonic acid (Kdo) residues. The lipid A moiety appears as a mixture of differently phosphorylated and acylated species and carries either linear or branched acyl moieties. Peritoneal injection of the LOS in mice increased higher gene expression of liver TLR2 than TLR4 (100-fold) and induced high IL-10 gene expression. A. muciniphila LOS was found to signal both through TLR4 and TLR2, whereas lipid A only induced TLR2 in a human cell line. We propose that the unique structure of the A. muciniphila LOS allows interaction with TLR2, thus generating an anti-inflammatory response as to compensate for the canonical inflammatory signaling associated with LOS and TLR4, rationalizing its beneficial host interaction., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
84. Gonococcal Mimitope Vaccine Candidate Forms a Beta-Hairpin Turn and Binds Hydrophobically to a Therapeutic Monoclonal Antibody.
- Author
-
Beernink PT, Di Carluccio C, Marchetti R, Cerofolini L, Carillo S, Cangiano A, Cowieson N, Bones J, Molinaro A, Paduano L, Fragai M, Beernink BP, Gulati S, Shaughnessy J, Rice PA, Ram S, and Silipo A
- Abstract
The spread of multidrug-resistant strains of Neisseria gonorrhoeae , the etiologic agent of gonorrhea, represents a global health emergency. Therefore, the development of a safe and effective vaccine against gonorrhea is urgently needed. In previous studies, murine monoclonal antibody (mAb) 2C7 was raised against gonococcal lipooligosaccharide (LOS). mAb 2C7 elicits complement-dependent bactericidal activity against gonococci, and its glycan epitope is expressed by almost every clinical isolate. Furthermore, we identified a peptide, cyclic peptide 2 (CP2) that mimicked the 2C7 LOS epitope, elicited bactericidal antibodies in mice, and actively protected in a mouse vaginal colonization model. In this study, we performed structural analyses of mAb 2C7 and its complex with the CP2 peptide by X-ray crystallography, NMR spectroscopy, and molecular dynamics (MD) simulations. The crystal structure of Fab 2C7 bound to CP2 showed that the peptide adopted a beta-hairpin conformation and bound the Fab primarily through hydrophobic interactions. We employed NMR spectroscopy and MD simulations to map the 2C7 epitope and identify the bioactive conformation of CP2. We also used small-angle X-ray scattering (SAXS) and native mass spectrometry to obtain further information about the shape and assembly state of the complex. Collectively, our new structural information suggests strategies for humanizing mAb 2C7 as a therapeutic against gonococcal infection and for optimizing peptide CP2 as a vaccine antigen., Competing Interests: The authors declare the following competing financial interest(s): SR and PAR are co-founders of STIRx, Inc. and hold equity in the company., (© 2024 The Authors. Published by American Chemical Society.)
- Published
- 2024
- Full Text
- View/download PDF
85. The Role of Lysozyme in the Formation of Bioinspired Silicon Dioxide.
- Author
-
Macchiagodena M, Fragai M, Gallo A, Pagliai M, and Ravera E
- Subjects
- Molecular Dynamics Simulation, Polyelectrolytes chemistry, Muramidase chemistry, Muramidase metabolism, Silicon Dioxide chemistry
- Abstract
Several organisms are able to polycondensate tetraoxosilicic(IV) acid to form silicon(IV) dioxide using polycationic molecules. According to an earlier mechanistic proposal, these molecules undergo a phase separation and recent experimental evidence appears to confirm this model. At the same time, polycationic proteins like lysozyme can also promote polycondensation of silicon(IV) dioxide, and they do so under conditions that are not compatible with liquid-liquid phase separation. In this manuscript we investigate this conundrum by molecular simulations., (© 2024 Wiley-VCH GmbH.)
- Published
- 2024
- Full Text
- View/download PDF
86. Machine Learning-Enhanced Quantum Chemistry-Assisted Refinement of the Active Site Structure of Metalloproteins.
- Author
-
Gigli L, Silva JM, Cerofolini L, Macedo AL, Geraldes CFGC, Suturina EA, Calderone V, Fragai M, Parigi G, Ravera E, and Luchinat C
- Subjects
- Humans, Models, Molecular, Matrix Metalloproteinase 12 chemistry, Matrix Metalloproteinase 12 metabolism, Catalytic Domain, Machine Learning, Metalloproteins chemistry, Quantum Theory
- Abstract
Understanding the fine structural details of inhibitor binding at the active site of metalloenzymes can have a profound impact on the rational drug design targeted to this broad class of biomolecules. Structural techniques such as NMR, cryo-EM, and X-ray crystallography can provide bond lengths and angles, but the uncertainties in these measurements can be as large as the range of values that have been observed for these quantities in all the published structures. This uncertainty is far too large to allow for reliable calculations at the quantum chemical (QC) levels for developing precise structure-activity relationships or for improving the energetic considerations in protein-inhibitor studies. Therefore, the need arises to rely upon computational methods to refine the active site structures well beyond the resolution obtained with routine application of structural methods. In a recent paper, we have shown that it is possible to refine the active site of cobalt(II)-substituted MMP12, a metalloprotein that is a relevant drug target, by matching to the experimental pseudocontact shifts (PCS) those calculated using multireference ab initio QC methods. The computational cost of this methodology becomes a significant bottleneck when the starting structure is not sufficiently close to the final one, which is often the case with biomolecular structures. To tackle this problem, we have developed an approach based on a neural network (NN) and a support vector regression (SVR) and applied it to the refinement of the active site structure of oxalate-inhibited human carbonic anhydrase 2 (hCAII), another prototypical metalloprotein target. The refined structure gives a remarkably good agreement between the QC-calculated and the experimental PCS. This study not only contributes to the knowledge of CAII but also demonstrates the utility of combining machine learning (ML) algorithms with QC calculations, offering a promising avenue for investigating other drug targets and complex biological systems in general.
- Published
- 2024
- Full Text
- View/download PDF
87. Targeting the Main Protease (M pro , nsp5) by Growth of Fragment Scaffolds Exploiting Structure-Based Methodologies.
- Author
-
Altincekic N, Jores N, Löhr F, Richter C, Ehrhardt C, Blommers MJJ, Berg H, Öztürk S, Gande SL, Linhard V, Orts J, Abi Saad MJ, Bütikofer M, Kaderli J, Karlsson BG, Brath U, Hedenström M, Gröbner G, Sauer UH, Perrakis A, Langer J, Banci L, Cantini F, Fragai M, Grifagni D, Barthel T, Wollenhaupt J, Weiss MS, Robertson A, Bax A, Sreeramulu S, and Schwalbe H
- Subjects
- Catalytic Domain, Magnetic Resonance Spectroscopy, Peptide Hydrolases metabolism, Protease Inhibitors metabolism, Antiviral Agents pharmacology, Molecular Docking Simulation, Drug Discovery methods, SARS-CoV-2 metabolism
- Abstract
The main protease M
pro , nsp5, of SARS-CoV-2 (SCoV2) is one of its most attractive drug targets. Here, we report primary screening data using nuclear magnetic resonance spectroscopy (NMR) of four different libraries and detailed follow-up synthesis on the promising uracil-containing fragment Z604 derived from these libraries. Z604 shows time-dependent binding. Its inhibitory effect is sensitive to reducing conditions. Starting with Z604, we synthesized and characterized 13 compounds designed by fragment growth strategies. Each compound was characterized by NMR and/or activity assays to investigate their interaction with Mpro . These investigations resulted in the four-armed compound 35b that binds directly to Mpro . 35b could be cocrystallized with Mpro revealing its noncovalent binding mode, which fills all four active site subpockets. Herein, we describe the NMR-derived fragment-to-hit pipeline and its application for the development of promising starting points for inhibitors of the main protease of SCoV2.- Published
- 2024
- Full Text
- View/download PDF
88. Multivalent Calixarene Complexation of a Designed Pentameric Lectin.
- Author
-
Flood RJ, Cerofolini L, Fragai M, and Crowley PB
- Subjects
- Lectins, Crystallography, X-Ray, Magnetic Resonance Spectroscopy, Binding Sites, Calixarenes chemistry
- Abstract
We describe complex formation between a designed pentameric β-propeller and the anionic macrocycle sulfonato-calix[8]arene ( sclx
8 ), as characterized by X-ray crystallography and NMR spectroscopy. Two crystal structures and15 N HSQC experiments reveal a single calixarene binding site in the concave pocket of the β-propeller toroid. Despite the symmetry mismatch between the pentameric protein and the octameric macrocycle, they form a high affinity multivalent complex, with the largest protein-calixarene interface observed to date. This system provides a platform for investigating multivalency.- Published
- 2024
- Full Text
- View/download PDF
89. Molecular Insights into O-Linked Sialoglycans Recognition by the Siglec-Like SLBR-N (SLBR UB10712 ) of Streptococcus gordonii .
- Author
-
Di Carluccio C, Cerofolini L, Moreira M, Rosu F, Padilla-Cortés L, Gheorghita GR, Xu Z, Santra A, Yu H, Yokoyama S, Gray TE, St Laurent CD, Manabe Y, Chen X, Fukase K, Macauley MS, Molinaro A, Li T, Bensing BA, Marchetti R, Gabelica V, Fragai M, and Silipo A
- Abstract
Streptococcus gordonii is a Gram-positive bacterial species that typically colonizes the human oral cavity, but can also cause local or systemic diseases. Serine-rich repeat (SRR) glycoproteins exposed on the S. gordonii bacterial surface bind to sialylated glycans on human salivary, plasma, and platelet glycoproteins, which may contribute to oral colonization as well as endocardial infections. Despite a conserved overall domain organization of SRR adhesins, the Siglec-like binding regions (SLBRs) are highly variable, affecting the recognition of a wide range of sialoglycans. SLBR-N from the SRR glycoprotein of S. gordonii UB10712 possesses the remarkable ability to recognize complex core 2 O -glycans. We here employed a multidisciplinary approach, including flow cytometry, native mass spectrometry, isothermal titration calorimetry, NMR spectroscopy from both protein and ligand perspectives, and computational methods, to investigate the ligand specificity and binding preferences of SLBR-N when interacting with mono- and disialylated core 2 O -glycans. We determined the means by which SLBR-N preferentially binds branched α2,3-disialylated core 2 O -glycans: a selected conformation of the 3'SLn branch is accommodated into the main binding site, driving the sTa branch to further interact with the protein. At the same time, SLBR-N assumes an open conformation of the CD loop of the glycan-binding pocket, allowing one to accommodate the entire complex core 2 O -glycan. These findings establish the basis for the generation of novel tools for the detection of specific complex O -glycan structures and pave the way for the design and development of potential therapeutics against streptococcal infections., Competing Interests: The authors declare no competing financial interest., (© 2024 The Authors. Published by American Chemical Society.)
- Published
- 2024
- Full Text
- View/download PDF
90. Site-Selective Functionalized PD-1 Mutant for a Modular Immunological Activity against Cancer Cells.
- Author
-
Fallarini S, Cerofolini L, Salobehaj M, Rizzo D, Gheorghita GR, Licciardi G, Capialbi DE, Zullo V, Sodini A, Nativi C, and Fragai M
- Subjects
- Humans, B7-H1 Antigen, Antibodies, Programmed Cell Death 1 Receptor genetics, Programmed Cell Death 1 Receptor chemistry, Neoplasms drug therapy, Neoplasms genetics
- Abstract
Targeting immune checkpoints is a well-established strategy in cancer therapy, and antibodies blocking PD-1/PD-L1 interactions to restore the immunological activity against cancer cells have been clinically validated. High-affinity mutants of the PD-1 ectodomain have recently been proposed as an alternative to antibodies to target PD-L1 on cancer cells, shedding new light on this research area. In this dynamic scenario, the PD-1 mutant, here reported, largely expands the chemical space of nonantibody and nonsmall-molecule inhibitor therapeutics that can be used to target cancer cells overexpressing PD-L1 receptors. The polyethylene glycol moieties and the immune response-stimulating carbohydrates, used as site-selective tags, represent the proof of concept for future applications.
- Published
- 2023
- Full Text
- View/download PDF
91. Combining Solid-State NMR with Structural and Biophysical Techniques to Design Challenging Protein-Drug Conjugates.
- Author
-
Cerofolini L, Vasa K, Bianconi E, Salobehaj M, Cappelli G, Bonciani A, Licciardi G, Pérez-Ràfols A, Padilla-Cortés L, Antonacci S, Rizzo D, Ravera E, Viglianisi C, Calderone V, Parigi G, Luchinat C, Macchiarulo A, Menichetti S, and Fragai M
- Subjects
- Humans, Pharmaceutical Preparations, Magnetic Resonance Spectroscopy, Crystallography, X-Ray, Carrier Proteins chemistry, Magnetic Resonance Imaging
- Abstract
Several protein-drug conjugates are currently being used in cancer therapy. These conjugates rely on cytotoxic organic compounds that are covalently attached to the carrier proteins or that interact with them via non-covalent interactions. Human transthyretin (TTR), a physiological protein, has already been identified as a possible carrier protein for the delivery of cytotoxic drugs. Here we show the structure-guided development of a new stable cytotoxic molecule based on a known strong binder of TTR and a well-established anticancer drug. This example is used to demonstrate the importance of the integration of multiple biophysical and structural techniques, encompassing microscale thermophoresis, X-ray crystallography and NMR. In particular, we show that solid-state NMR has the ability to reveal effects caused by ligand binding which are more easily relatable to structural and dynamical alterations that impact the stability of macromolecular complexes., (© 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.)
- Published
- 2023
- Full Text
- View/download PDF
92. Elucidating the concentration-dependent effects of thiocyanate binding to carbonic anhydrase.
- Author
-
Silva JM, Cerofolini L, Carvalho AL, Ravera E, Fragai M, Parigi G, Macedo AL, Geraldes CFGC, and Luchinat C
- Subjects
- Humans, Thiocyanates, Ligands, Cobalt chemistry, Binding Sites, Protein Binding, Carbonic Anhydrases chemistry
- Abstract
Many proteins naturally carry metal centers, with a large share of them being in the active sites of several enzymes. Paramagnetic effects are a powerful source of structural information and, therefore, if the native metal is paramagnetic, or it can be functionally substituted with a paramagnetic one, paramagnetic effects can be used to study the metal sites, as well as the overall structure of the protein. One notable example is cobalt(II) substitution for zinc(II) in carbonic anhydrase. In this manuscript we investigate the effects of sodium thiocyanate on the chemical environment of the metal ion of the human carbonic anhydrase II. The electron paramagnetic resonance (EPR) titration of the cobalt(II) protein with thiocyanate shows that the EPR spectrum changes from A-type to C-type on passing from 1:1 to 1:1000-fold ligand excess. This indicates the occurrence of a change in the electronic structure, which may reflect a sizable change in the metal coordination environment in turn caused by a modification of the frozen solvent glass. However, paramagnetic nuclear magnetic resonance (NMR) data indicate that the metal coordination cage remains unperturbed even in 1:1000-fold ligand excess. This result proves that the C-type EPR spectrum observed at large ligand concentration should be ascribed to the low temperature at which EPR measurements are performed, which impacts on the structure of the protein when it is destabilized by a high concentration of a chaotropic agent., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
93. Integration of NMR Spectroscopy in an Analytical Workflow to Evaluate the Effects of Oxidative Stress on Abituzumab: Beyond the Fingerprint of mAbs.
- Author
-
Cerofolini L, Ravera E, Fischer C, Trovato A, Sacco F, Palinsky W, Angiuoni G, Fragai M, and Baroni F
- Subjects
- Workflow, Magnetic Resonance Spectroscopy, Hydrogen Peroxide, Antibodies, Monoclonal chemistry
- Abstract
The assessment of the higher-order structure (HOS) by NMR is a powerful methodology to characterize the structural features of biologics. Forced oxidative stress studies are used to investigate the stability profile, to develop pharmaceutical formulations and analytical methods. Here, the effects of forced oxidative stress by H
2 O2 on the monoclonal antibody Abituzumab have been characterized by a multianalytical approach combining NMR spectroscopy, mass spectrometry, differential scanning calorimetry, surface plasmon resonance, computational tools, and bioassays. This integrated strategy has provided qualitative and semiquantitative characterization of the samples and information at residue level of the effects that oxidation has on the HOS of Abituzumab, correlating them to the loss of the biological activity.- Published
- 2023
- Full Text
- View/download PDF
94. Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design.
- Author
-
Donati G, D'Amore VM, Russomanno P, Cerofolini L, Amato J, Marzano S, Salobehaj M, Rizzo D, Assoni G, Carotenuto A, La Pietra V, Arosio D, Seneci P, Fragai M, Brancaccio D, Di Leva FS, and Marinelli L
- Abstract
Today it is widely recognized that the PD-1/PD-L1 axis plays a fundamental role in escaping the immune system in cancers, so that anti-PD-1/PD-L1 antibodies have been evaluated for their antitumor properties in more than 1000 clinical trials. As a result, some of them have entered the market revolutionizing the treatment landscape of specific cancer types. Nonetheless, a new era based on the development of small molecules as anti PD-L1 drugs has begun. There are, however, some limitations to advancing these compounds into clinical stages including the possible difficulty in counteracting the PD-1/PD-L1 interaction in vivo, the discrepancy between the in vitro IC
50 (HTFR assay) and cellular EC50 (immune checkpoint blockade co-culture assay), and the differences in ligands' affinity between human and murine PD-L1, which can affect their preclinical evaluation. Here, an extensive theoretical study, assisted by MicroScale Thermophoresis binding assays and NMR experiments, was performed to provide an atomistic picture of the binding event of three representative biphenyl-based compounds in both human and murine PD-L1. Structural determinants of the species' specificity were unraveled, providing unprecedented details useful for the design of next generation anti-PD-L1 molecules., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.)- Published
- 2023
- Full Text
- View/download PDF
95. Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays.
- Author
-
Bellomo G, Paciotti S, Concha-Marambio L, Rizzo D, Wojdaƚa AL, Chiasserini D, Gatticchi L, Cerofolini L, Giuntini S, De Luca CMG, Ma Y, Farris CM, Pieraccini G, Bologna S, Filidei M, Ravera E, Lelli M, Moda F, Fragai M, Parnetti L, and Luchinat C
- Subjects
- Humans, alpha-Synuclein chemistry, Lipoproteins, Synucleinopathies, Parkinson Disease diagnosis
- Abstract
Background: Aggregation of α-synuclein (α-syn) is a prominent feature of Parkinson's disease (PD) and other synucleinopathies. Currently, α-syn seed amplification assays (SAAs) using cerebrospinal fluid (CSF) represent the most promising diagnostic tools for synucleinopathies. However, CSF itself contains several compounds that can modulate the aggregation of α-syn in a patient-dependent manner, potentially undermining unoptimized α-syn SAAs and preventing seed quantification., Methods: In this study, we characterized the inhibitory effect of CSF milieu on detection of α-syn aggregates by means of CSF fractionation, mass spectrometry, immunoassays, transmission electron microscopy, solution nuclear magnetic resonance spectroscopy, a highly accurate and standardized diagnostic SAA, and different in vitro aggregation conditions to evaluate spontaneous aggregation of α-syn., Results: We found the high-molecular weight fraction of CSF (> 100,000 Da) to be highly inhibitory on α-syn aggregation and identified lipoproteins to be the main drivers of this effect. Direct interaction between lipoproteins and monomeric α-syn was not detected by solution nuclear magnetic resonance spectroscopy, on the other hand we observed lipoprotein-α-syn complexes by transmission electron microscopy. These observations are compatible with hypothesizing an interaction between lipoproteins and oligomeric/proto-fibrillary α-syn intermediates. We observed significantly slower amplification of α-syn seeds in PD CSF when lipoproteins were added to the reaction mix of diagnostic SAA. Additionally, we observed a decreased inhibition capacity of CSF on α-syn aggregation after immunodepleting ApoA1 and ApoE. Finally, we observed that CSF ApoA1 and ApoE levels significantly correlated with SAA kinetic parameters in n = 31 SAA-negative control CSF samples spiked with preformed α-syn aggregates., Conclusions: Our results describe a novel interaction between lipoproteins and α-syn aggregates that inhibits the formation of α-syn fibrils and could have relevant implications. Indeed, the donor-specific inhibition of CSF on α-syn aggregation explains the lack of quantitative results from analysis of SAA-derived kinetic parameters to date. Furthermore, our data show that lipoproteins are the main inhibitory components of CSF, suggesting that lipoprotein concentration measurements could be incorporated into data analysis models to eliminate the confounding effects of CSF milieu on α-syn quantification efforts., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
96. HuR modulation counteracts lipopolysaccharide response in murine macrophages.
- Author
-
Bonomo I, Assoni G, La Pietra V, Canarutto G, Facen E, Donati G, Zucal C, Genovese S, Micaelli M, Pérez-Ràfols A, Robbiati S, Kontoyannis DL, De Matteo M, Fragai M, Seneci P, Marinelli L, Arosio D, Piazza S, and Provenzani A
- Subjects
- Mice, Animals, Macrophages metabolism, RNA metabolism, RNA, Messenger genetics, Lipopolysaccharides pharmacology, Lipopolysaccharides metabolism, ELAV-Like Protein 1 genetics, ELAV-Like Protein 1 metabolism
- Abstract
Lipopolysaccharide (LPS) exposure to macrophages induces an inflammatory response, which is regulated at the transcriptional and post-transcriptional levels. HuR (ELAVL1) is an RNA-binding protein that regulates cytokines and chemokines transcripts containing AU/U-rich elements (AREs) and mediates the LPS-induced response. Here, we show that small-molecule tanshinone mimics (TMs) inhibiting HuR-RNA interaction counteract LPS stimulus in macrophages. TMs exist in solution in keto-enolic tautomerism, and molecular dynamic calculations showed the ortho-quinone form inhibiting binding of HuR to mRNA targets. TM activity was lost in vitro by blocking the diphenolic reduced form as a diacetate, but resulted in prodrug-like activity in vivo. RNA and ribonucleoprotein immunoprecipitation sequencing revealed that LPS induces a strong coupling between differentially expressed genes and HuR-bound genes, and TMs reduced such interactions. TMs decreased the association of HuR with genes involved in chemotaxis and immune response, including Cxcl10, Il1b and Cd40, reducing their expression and protein secretion in primary murine bone marrow-derived macrophages and in an LPS-induced peritonitis model. Overall, TMs show anti-inflammatory properties in vivo and suggest HuR as a potential therapeutic target for inflammation-related diseases., Competing Interests: Competing interests The authors declare no competing or financial interests., (© 2023. Published by The Company of Biologists Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
97. Solid-state NMR - a complementary technique for protein framework characterization.
- Author
-
Cerofolini L, Ramberg KO, Padilla LC, Antonik P, Ravera E, Luchinat C, Fragai M, and Crowley PB
- Subjects
- Magnetic Resonance Spectroscopy methods, X-Ray Diffraction, Freezing, Proteins, Magnetic Resonance Imaging
- Abstract
Protein frameworks are an emerging class of biomaterial with medical and technological applications. Frameworks are studied mainly by X-ray diffraction or scattering techniques. Complementary strategies are required. Here, we report solid-state NMR analyses of a microcrystalline protein-macrocycle framework and the rehydrated freeze-dried protein. This methodology may aid the characterization of low-crystallinity frameworks.
- Published
- 2023
- Full Text
- View/download PDF
98. Large Protein Assemblies for High-Relaxivity Contrast Agents: The Case of Gadolinium-Labeled Asparaginase.
- Author
-
Licciardi G, Rizzo D, Salobehaj M, Massai L, Geri A, Messori L, Ravera E, Fragai M, and Parigi G
- Subjects
- Gadolinium, Magnetic Resonance Imaging methods, Chelating Agents, Contrast Media, Asparaginase
- Abstract
Biologics are emerging as the most important class of drugs and are used to treat a large variety of pathologies. Most of biologics are proteins administered in large amounts, either by intramuscular injection or by intravenous infusion. Asparaginase is a large tetrameric protein assembly, currently used against acute lymphoblastic leukemia. Here, a gadolinium(III)-DOTA derivative has been conjugated to asparaginase, and its relaxation properties have been investigated to assess its efficiency as a possible theranostic agent. The field-dependent
1 H longitudinal relaxation measurements of water solutions of gadolinium(III)-labeled asparaginase indicate a very large increase in the relaxivity of this paramagnetic protein complex with respect to small gadolinium chelates, opening up the possibility of its use as an MRI contrast agent.- Published
- 2022
- Full Text
- View/download PDF
99. Solid-state NMR methods for the characterization of bioconjugations and protein-material interactions.
- Author
-
Cerofolini L, Parigi G, Ravera E, Fragai M, and Luchinat C
- Subjects
- Magnetic Resonance Spectroscopy methods, Proteins chemistry, Magnetic Resonance Imaging
- Abstract
Protein solid-state NMR has evolved dramatically over the last two decades, with the development of new hardware and sample preparation methodologies. This technique is now ripe for complex applications, among which one can count bioconjugation, protein chemistry and functional biomaterials. In this review, we provide our account on this aspect of protein solid-state NMR., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
100. Functionalized Hyaluronic Acid for " In Situ " Matrix Metalloproteinase Inhibition: A Bioactive Material to Treat the Dry Eye Sydrome.
- Author
-
Burgalassi S, Fragai M, Francesconi O, Cerofolini L, Monti D, Leone G, Lamponi S, Greco G, Magnani A, and Nativi C
- Subjects
- Humans, Hyaluronoglucosaminidase therapeutic use, Matrix Metalloproteinases, Polysaccharides, Dry Eye Syndromes drug therapy, Hyaluronic Acid pharmacology
- Abstract
Hyaluronic acid (HA) is a naturally occurring polysaccharide with many molecular functions, including maintaining the structure and physiology of the tissues, tissue remodeling, and inflammation. HA is found naturally in physiological tear fluid, possesses excellent mucus-layer-adhesive properties, and is successfully employed in the treatment of dry eye syndrome (DES). However, HA has as major drawback: its rapid in vivo degradation by hyaluronidase. We report on a unique material, namely, HA- 3 , obtained by the functionalization of HA with the metalloproteinase inhibitor 3 (MMPI). This material is characterized by an increased resistance to hyaluronidase degradation, associated with MMP inhibition properties. The ability of HA- 3 to prevent dehydration of human corneal epithelial cells in vitro and in vivo may accelerate the development of more efficient DES treatment and broaden the application of HA in human diseases.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.